An Updated Comprehensive Pharmacovigilance Study of Drug-Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data.

导出 LinkOut

翻译打印收藏纠错

作者： Li,Kunyu ^[1] ; Shi,Shuping ^[2] ; Su,Chang ^[2] ; Cao,Yiyue ^[3] ; Xiong,Qinyu ^[4] ; Zhang,Ting ^[4] ; Wu,Bin ^[1]

作者单位： Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China. ^[1] West China School of Pharmacy, Sichuan University, Chengdu, China. ^[2] State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. ^[3] School of Mathematics, Sichuan University, Chengdu, China. ^[4]

关键词 Adverse Events Reporting System information component pharmacovigilance reporting odds ratio thrombocytopenia

主题词美国(United States);人类(Humans);美国食品和药物管理局(United States Food and Drug Administration);抗体, 单克隆(Antibodies, Monoclonal);药物副反应报告系统(Adverse Drug Reaction Reporting Systems);血小板减少(Thrombocytopenia);肝素(Heparin)

DOI 10.1002/jcph.2389

PMID 38041205

发布时间 2024-04-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交